BSESampre Nutritions LtdHighNeutral
Announced Fri, 29 May · 17:40 IST

In compliance with Regulation 33 of the SEBI (LODR) Regulations, 2015, the audited standalone and consolidated financial results along with the independent auditor''s report, and declaration ....

Revenue Growth 20pctPat Growth 25pctResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.2%1-day move
₹13.10
prior close
₹13.09
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.9+3.9+3.1+3.1-0.2-4.6-7.1-12.1-16.4-12.2-41.1-38.9
Up moveDown movePending
AI summary

Sampre Nutritions Limited reported strong financial turnaround for FY2026. Standalone total income grew 72.8% to Rs 4,405.76 Lakhs from Rs 2,549.87 Lakhs in the previous year. The company returned to profitability with standalone PAT of Rs 386.55 Lakhs compared to a loss of Rs 730.92 Lakhs in FY2025. On consolidated basis, total income was Rs 4,377.92 Lakhs with PAT of Rs 307.67 Lakhs (vs loss of Rs 767.23 Lakhs). The auditors from N G Rao & Associates issued an unmodified (clean) opinion on both standalone and consolidated results. During the year, the company subscribed to a new wholly-owned subsidiary, Sampre Nutritions FZCO. Cash flow from operations remained negative at Rs 109.71 Lakhs (consolidated), indicating working capital pressure despite improved profitability.

Likely market impact

The company has demonstrated significant recovery with revenue nearly doubling and return to profit after two consecutive years of losses. However, negative operating cash flow and inventory buildup may concern investors despite the clean audit opinion.